Objectives: To investigate the outcome of fetuses with intra-abdominal umbilical vein varix (FIUVV). Methods: A retrospective cohort study of cases of FIUVV followed in a tertiary university hospital was carried out. A systematic review and a meta-analysis of the existing literature were also performed to assess the incidence of chromosomal anomalies, Small for Gestational Age (SGA) infants and Intra-Uterine Fetal Demise (IUFD) and to pool relative risk (RR) estimates on the relationship between the presence of associated additional ultrasound anomalies and the occurrence of these outcomes. The potential relationship between ultrasound characteristics of the varix and IUFD in fetuses with isolated FIUVV was also tested. Results: Thirteen cases of FIUVV were included in the cohort. A total of 12 studies with 336 cases was included in the systematic review comprising our cohort. FIUVV was associated with other US anomalies in 55/336 (16%) of cases. The rate of chromosomal anomalies was 7.5% (95% CI 2.2-15.7) and the overall the rate of IUFD was 6.5% (95% CI 2.3-12.7). The fetuses with additional ultrasound anomalies had an increased risk of chromosomal anomalies (RR 9.50; 95% CI 3.5-25.3, p<0.0001) and IUFD (RR 3.07; 95% CI 1.2-7.7) compared with those with an isolated FIUVV. In fetuses with isolated FIUVV, the incidence of IUFD was 2.8% (95% CI 1.2-5.5). There was no factor predictive of IUFD, comparing gestational age at diagnosis (23.1 ±3.5weeks vs. 26.8 ± 5.7 weeks, p=0.09), varix size at diagnosis (10.5 ± 2.3 mm vs. 10.9 ±4.0 mm, p=0.79), appearance before 22 weeks (12.5% vs. 9.1% p=0.77) and thrombosis of the varix (12.5% vs. 0% p=0.4) in cases with and without fetal demise respectively. Conclusions: The presence of associated ultrasound anomalies is an important prognostic factor for chromosomal anomalies and IUFD in fetuses with FIUVV. Isolated FIUVV also require close antenatal surveillance for an increased risk of IUFD with no known predisposing factor.
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Prenatal and postnatal evolution of 14 cases of fetal splenic cysts Objectives: The aim of this study was to evaluate the prenatal and postnatal evolution of fetal splenic cysts in a retrospective cohort. Methods: All cases of fetal splenic cysts discovered during routine ultrasound scan, from 2014 to 2016, and referred to Montpellier and Nimes University's Hospital Centre (France), were retrospectively collected. For each case, several parameters were reported: gestational age at diagnosis, fetal gender, number of cysts, isolated or associated malformations, MRI confirmation, differential diagnosis, evolution during pregnancy, immediate postnatal confirmation (ultrasound/MRI), and postnatal evolution at 6 months. Results: Sixteen cases of suspected fetal splenic cysts were retrieved during the study period. Two of them were finally diagnosed to be one hepatic cyst and an intestinal duplication, leaving 14 cases of real splenic cysts. Median gestational age at diagnosis were 30.1 weeks of gestation (1st quartile-3rd quartile: 26.9-32.9 weeks). A unique cyst was present in 78.6% (11/14) whereas 2 cysts were observed in 14.3% and three cysts in 7.1%. Fetal gender was mainly male (10/14). Fetal MRI confirmed the presence of all cysts. During the pregnancy, cysts remained the same (78.6%) or disappeared (21.4%). At birth, ultrasound scan confirmed the persistence of the cysts in the 11 cases (78.6%). Ultrasound scan at 6 months of life found total disappearance of the cysts in 4 cases (36.4%), spontaneous reduction from 2 cysts to 1 in 2 cases (18.2%) and persistence of the cysts in 5 cases (45.4%). None of them was responsible for any symptoms. Conclusions: Fetal splenic cyst are benign images, always isolated, usually unique and mainly found during 3rd trimester ultrasound. Their evolution is to disappear spontaneously during the pregnancy (21.4%), or at 6 month of life (36.4%) leaving only half of them to remain at 6 months. They are not responsible for any clinical symptoms. 
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